Covidien Receives FDA Approval for Nellcor

The U.S. Food and Drug Administration has granted Covidien 510(k) clearance to market the company’s Nellcor Bedside SpO2 Patient Monitoring System.

Advertisement

The Nellcor Bedside SpO2 system with OxiMax technology continuously monitors SpO2 and pulse rate for adult, pediatric and neonatal patients, giving clinicians instant access to comprehensive trending respiratory information. The system also includes technology to help differentiate between serious and minor events and reduce clinically insignificant oxygen desaturation alarms.

Learn more about Covidien.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.